Analytical evaluation of the Abbott ARCHITECT sirolimus assay

被引：0
|
作者：
Kahn, S. E. [1 ]
Vazquez, D. [1 ]
Meyer, P. [1 ]
Dickson, D. [2 ]
Kenney, D. [2 ]
Edwards, M. [3 ]
Haverstick, M. [3 ]
机构：
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[2] Fujirebio Diagnost, Malvern, PA USA
[3] Univ Virginia Hlth Syst, Charlottesville, VA USA
来源：
CLINICAL CHEMISTRY | 2008年 / 54卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
A40
引用
收藏
页码：A14 / A14
页数：1
相关论文
共 50 条
  • [41] Analytical and clinical comparison of Elecsys syphilis (Roche®) - Architect syphilis TP and reformulated Architect syphilis TP (Abbott®) assay
    De Keukeleire, Steven
    Desmet, Stefanie
    Lagrou, Katrien
    Oosterlynck, Julie
    Verhulst, Manon
    Van Besien, Jessica
    Saegeman, Veroniek
    Reynders, Marijke
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (03) : 210 - 212
  • [42] Performance of Abbott ARCHITECT® AUSAB® assay for the US
    Wiesner, D. C.
    Dellamorte, M.
    Kramer, C.
    Rodriguez, T.
    Herrmann, R.
    Rios, A.
    Bartko, K.
    Williams, G.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A49 - A49
  • [43] Performance characteristics of the Abbott ARCHITECT® Progesterone assay
    Rufo, G
    Brookhart, P
    Barnes, W
    Frels, M
    Sheu, M
    White, M
    Chan, S
    Lauren, L
    McHale, P
    Bartko, K
    CLINICAL CHEMISTRY, 2005, 51 : A235 - A235
  • [44] ANALYTICAL EVALUATION OF PHENYTOIN, PHENOBARBITAL, VALPROIC ACID AND VANCOMYCIN ASSAYS ON THE ABBOTT ARCHITECT™
    Schouwers, S.
    Verstraete, A.
    Stove, V.
    ACTA CLINICA BELGICA, 2010, 65 (03): : 211 - 211
  • [45] Multi-site evaluation of an assay in development for sirolimus on the abbott ARCHITECTO analyzer
    Grenier, F.
    Ali, S.
    Syed, H.
    Ryan, W.
    Sluss, P. M.
    Ming, L.
    Pui-Yuen, W.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A72 - A73
  • [46] Evaluation of an assay in development for intact parathyroid hormone (PTH) on the Abbott ARCHITECT® analyzer
    Martens, M
    Megens, M
    van Wanrooij, M
    van Doorn, D
    Dhein, J
    Eppinger-Albrecht, M
    Hausmann, M
    Jenne, N
    CLINICAL CHEMISTRY, 2005, 51 : A242 - A242
  • [47] Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer
    El Mouatani, Ahmed
    Rotaru, Irina
    Beaudeux, Jean-Louis
    Hennequin, Carole
    ANNALES DE BIOLOGIE CLINIQUE, 2018, 76 (03) : 308 - 312
  • [48] Evaluation of the new digoxin assay on the Abbott architect analyser and its correlation with the AxSYM Digoxin II assay
    Outeda-Macias, M.
    Salvador-Garrido, P.
    Espana Valino, L.
    Garcia Queiruga, M.
    Pedreira Vazquez, I
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 502 - 502
  • [49] Multicentric analytical and clinical comparison of Elecsys Syphilis (Roche®), Architect Syphilis TP and Reformulated Architect Syphilis TP (Abbott®) assay
    De Keukeleire, Steven
    De Smet, Stefanie
    Lagrou, Katrien
    Oosterlynck, Julie
    Verhulst, Manon
    Serru, Jessica
    Saegeman, Veroniek
    Reynders, Marijke
    ACTA CLINICA BELGICA, 2016, 71 : 24 - 24
  • [50] Next generation direct bilirubin assay for the Abbott AEROSET and Abbott ARCHITECT cSystems
    Muthukumar, A.
    Runnels, L.
    Satomura, S.
    Tanimoto, K.
    Bozimowski, D.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A234 - A234
12345